Prophylactic peritoneal dialysis catheter does not decrease time to achieve a negative fluid balance after the Norwood procedure: a randomized controlled trial
Lindsay M Ryerson, Andrew S Mackie, Joseph Atallah, Ari R Joffe, Ivan M Rebeyka, David B Ross, Ian Adatia, Lindsay M Ryerson, Andrew S Mackie, Joseph Atallah, Ari R Joffe, Ivan M Rebeyka, David B Ross, Ian Adatia
Abstract
Objective: Infants and children who undergo cardiopulmonary bypass and cardiac surgery are at risk of postoperative fluid overload. Peritoneal dialysis catheter (PDC) and peritoneal dialysis are reported to be effective means of postoperative fluid management. We sought to test the hypothesis that PDC insertion in the operating room at the time of Norwood palliation would decrease the time to achieve a negative fluid balance in a group of neonates with hypoplastic left heart syndrome.
Methods: A single center randomized controlled trial was performed. We randomized neonates with hypoplastic left heart syndrome to prophylactic PDC, with or without dialysis, or standard care (ie, no PDC).
Results: Twenty-two neonates were included; 10 were randomized to PDC and 12 were randomized to standard care. The mean time to first postoperative negative fluid balance was 2.70 ± 1.06 days for the prophylactic PDC group and 2.67 ± 0.65 days for the standard care group (P = .93). There was no difference between the 2 groups in time to lactate ≤ 2 mmol/L, maximum vasoactive-inotrope score on postoperative days 2 to 5, time to sternal closure, time to first extubation, modified clinical outcome score, or hospital length of stay. Twenty-one patients (95%) survived to hospital discharge. Four patients randomized to prophylactic PDC had 1 or more serious adverse events compared with no patients in the standard care group (P = .03).
Conclusions: Prophylactic PDC, with or without dialysis, did not decrease the time to achieve a negative fluid balance after the Norwood procedure, did not alter physiological variables postoperatively, and was associated with more severe adverse events.
Trial registration: ClinicalTrials.gov NCT01215240.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Source: PubMed
Aankomende klinische onderzoeken
-
Magnus MedicalCongressionally Directed Medical Research ProgramsWerving
-
Nicholas ButowskiSiren BiotechnologyNog niet aan het wervenGlioom | Hersenen neoplasma | Terugkerende hooggradige gliomenVerenigde Staten
-
State University of New York at BuffaloNog niet aan het wervenBetrokkenheid van de patiëntVerenigde Staten
-
Poitiers University HospitalNog niet aan het werven
-
Assistance Publique - Hôpitaux de ParisNog niet aan het wervenSikkelcelziekte | Vaso-occlusieve crisis
-
University of California, IrvineWervingHersenkanker | Kanker van het CZS | Kanker van het zenuwstelsel | Hersenkanker UitgezaaidVerenigde Staten
-
Qualia Life SciencesWerving
-
Guangdong Raynovent Biotech Co., LtdNog niet aan het wervenFundamentele wetenschap
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationWervingVolwassenen | Digitale assistentie voor slechtzienden | Visuele beperkingenHongkong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Nog niet aan het wervenDuctaal adenocarcinoom van de alvleesklier (PDAC)
-
Sun Yat-sen UniversityNog niet aan het wervenStoppen met roken | AI-agent | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityNog niet aan het werven